Study tests simpler HIV treatment: two drugs vs. three

NCT ID NCT05979311

Ongoing Disease control Sponsor: ViiV Healthcare Source: ClinicalTrials.gov ↗

Summary

This study compares two daily pill regimens for adults with HIV who are starting treatment for the first time. It tests whether a simpler two-drug combination works as well as a standard three-drug combination at keeping the virus under control. Researchers will also check for side effects and see how satisfied participants are with their treatment over 96 weeks.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

GSK Investigational Site

Ciudad Autonoma de Buenos Aire, C1425AWK, Argentina
GSK Investigational Site

Córdoba, X5000JJS, Argentina
GSK Investigational Site

Antwerp, 2000, Belgium
GSK Investigational Site

Brussels, 1000, Belgium
GSK Investigational Site

Ghent, 9000, Belgium
GSK Investigational Site

Hvidovre, 2650, Denmark
GSK Investigational Site

Bordeaux, 33000, France
GSK Investigational Site

Bordeaux, 33076, France
GSK Investigational Site

Lyon, 31059, France
GSK Investigational Site

Montpellier, 34090, France
GSK Investigational Site

Nice, 06202, France
GSK Investigational Site

Nîmes, 30029, France
GSK Investigational Site

Paris, 75012, France
GSK Investigational Site

Paris, 75013, France
GSK Investigational Site

Paris, 75018, France
GSK Investigational Site

Paris, 75970, France
GSK Investigational Site

Berlin, 10787, Germany
GSK Investigational Site

Cologne, 50668, Germany
GSK Investigational Site

Frankfurt, 60590, Germany
GSK Investigational Site

Hamburg, 20146, Germany
GSK Investigational Site

München, 80336, Germany
GSK Investigational Site

Athens, 106 76, Greece
GSK Investigational Site

Athens, 11 527, Greece
GSK Investigational Site

Thessaloniki, 54635, Greece
GSK Investigational Site

Dublin, 7, Ireland
GSK Investigational Site

Dublin, D09 V2N0, Ireland
GSK Investigational Site

Haifa, 31096, Israel
GSK Investigational Site

Ramat Gan, 52621, Israel
GSK Investigational Site

Rehovot, 76100, Israel
GSK Investigational Site

Tel Aviv, 64239, Israel
GSK Investigational Site

Bari, 70124, Italy
GSK Investigational Site

Bergamo, 24127, Italy
GSK Investigational Site

Padua, 35128, Italy
GSK Investigational Site

Pavia, 27100, Italy
GSK Investigational Site

Sassari, 07100, Italy
GSK Investigational Site

Aichi, 460-0001, Japan
GSK Investigational Site

Osaka, 540-0006, Japan
GSK Investigational Site

Tokyo, 108-8639, Japan
GSK Investigational Site

Tokyo, 162-8655, Japan
GSK Investigational Site

Mérida, 97070, Mexico
GSK Investigational Site

Bydgoszcz, 85-030, Poland
GSK Investigational Site

Lodz, 91-347, Poland
GSK Investigational Site

Wroclaw, 50-136, Poland
GSK Investigational Site

Aveiro, 3814-501, Portugal
GSK Investigational Site

Porto, 4099-001, Portugal
GSK Investigational Site

Badalona, 08916, Spain
GSK Investigational Site

Barcelona, 08036, Spain
GSK Investigational Site

Elche Alicante, 03203, Spain
GSK Investigational Site

La Laguna-Tenerife, 35010, Spain
GSK Investigational Site

Madrid, 28040, Spain
GSK Investigational Site

Madrid, 28041, Spain
GSK Investigational Site

Madrid, 28046, Spain
GSK Investigational Site

Marbella, 29603, Spain
GSK Investigational Site

Palma de Mallorca, 07120, Spain
GSK Investigational Site

Palma de Mallorca, 7198, Spain
GSK Investigational Site

Valencia, 46014, Spain
GSK Investigational Site

Stockholm, SE-14186, Sweden
GSK Investigational Site

Basel, 4031, Switzerland
GSK Investigational Site

Zurich, 8005, Switzerland
GSK Investigational Site

Glasgow, G12 OYN, United Kingdom
GSK Investigational Site

London, E9 6SR, United Kingdom
GSK Investigational Site

London, SE5 8AF, United Kingdom
GSK Investigational Site

London, W1D 6AQ, United Kingdom
GSK Investigational Site

London, W2 1NY, United Kingdom

Conditions

Explore the condition pages connected to this study.

HIV HIV INFECTIONS